Cargando…

Pharmacodynamics and pharmacokinetics of ciprofloxacin during sustained low-efficiency dialysis

Detalles Bibliográficos
Autores principales:	Olsen, K, Plumb, T, Reardon, N, Bogard, K, Branch-Woods, A, Peitz, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4069608/ http://dx.doi.org/10.1186/cc13592

Ejemplares similares

Pharmacokinetics and pharmacodynamics of esomeprazole and ranitidine during continuous venovenous hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2013)

Pharmacokinetic‐pharmacodynamic integration of enrofloxacin and its metabolite ciprofloxacin in buffalo calves
por: Daundkar, Prashant S., et al.
Publicado: (2015)

Sustained low-efficiency dialysis for renal replacement therapy in the ICU: a cost-benefit analysis of the years 2006 to 2010
por: Neuenfeldt, T, et al.
Publicado: (2012)

No pharmacodynamic (PD) and pharmacokinetic (PK) interaction of riociguat (BAY 63-2521) and aspirin
por: Frey, Reiner, et al.
Publicado: (2011)

5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE
por: Saunthararajah, Y., et al.
Publicado: (2023)

Pharmacokinetic–pharmacodynamic analysis of human purified C1-esterase inhibitor in patients with sepsis
por: Dolzhenkova, L, et al.
Publicado: (2008)

Dialytic techniques in critical patients: slow low-efficient daily dialysis or CVVHDF?
por: Caramelo, N, et al.
Publicado: (2006)

Warfarin pharmacodynamics and pharmacokinetics are not affected by the soluble guanylate cyclase stimulator riociguat (BAY 63-2521)
por: Frey, Reiner, et al.
Publicado: (2009)

Awakening and Breathing Coordination, Delirium Monitoring and Early Mobility bundle in adult ICU patients: a preliminary cost analysis
por: Peitz, G, et al.
Publicado: (2014)

Pharmacokinetics of meropenem in septic patients on sustained low-efficiency dialysis: a population pharmacokinetic study
por: Braune, Stephan, et al.
Publicado: (2018)

Pharmacokinetic (PK) and pharmacodynamic analyses of once- and twice-daily darunavir/ritonavir (DRV/r) in the ODIN trial
por: Sekar, V, et al.
Publicado: (2010)

Safety, pharmacokinetics, and pharmacodynamics of 4-hour intravenous infusion of eritoran tetrasodium in healthy Japanese and Caucasian males
por: Okubo, Y, et al.
Publicado: (2011)

A phase 1 evaluation of the pharmacokinetic/pharmacodynamic interaction of the antimalarial agents KAE609 and piperaquine (PPQ)
por: Stein, Daniel S, et al.
Publicado: (2014)

Pharmacokinetic/pharmacodynamic analysis of linezolid in critically ill patients with severe sepsis treated with renal replacement therapy
por: Barrasa González, H, et al.
Publicado: (2015)

Utilization of slow low-efficiency dialysis may help to optimize the need for continuous renal replacement therapy in Indian ICUs
por: Majumdar, A, et al.
Publicado: (2009)

A mild form of a Stevens-Johnson syndrome to ciprofloxacin
por: Madalan, Elena, et al.
Publicado: (2014)

Pharmacokinetics of daptomycin in patients undergoing low-flow continuous venovenous hemodiafiltration
por: Ide, TI, et al.
Publicado: (2015)

Optimizing the dosing regimen of linezolid in critically ill septic patients undergoing continuous hemodiafiltration using a pharmacokinetic/pharmacodynamic analysis and monte carlo simulation
por: Barrasa González, H, et al.
Publicado: (2015)

Pharmacodynamic analysis and concentration mapping for efficient delivery through the FUS-induced BBB opening in non-human primates in vivo
por: Samiotaki, Gesthimani, et al.
Publicado: (2015)

P-042: POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS ANALYSIS OF HYDROXYUREA, IN ADULT PATIENTS WITH SICKLE CELL DISEASE (SCD) RECEIVING BOTH TABLETS OR CAPSULES FORMULATIONS, AND EVALUATION OF DISEASE MARKERS
por: P., BARTOLUCCI, et al.
Publicado: (2022)

Susceptibility to ciprofloxacin of Escherichia coli strains isolated from patients with chronic kidney disease
por: Ionete, Oana Mariana, et al.
Publicado: (2014)

Pharmacodynamic analysis of an agonistic antibody to the costimulatory receptor GITR
por: Moody, Gordon, et al.
Publicado: (2015)

1316. Pharmacokinetic/Pharmacodynamic Analyses of Cefiderocol in Critically Ill Patients
por: Katsube, Takayuki, et al.
Publicado: (2020)

5613464 INTEGRATION OF PHARMACOKINETIC AND PHARMACODYNAMIC MODELS TO MULTI-CRITERIA DECISION ANALYSIS (MCDA) FOR PROSPECTIVE ASSESSMENT OF THE RISK-BENEFIT RATIO OF ORAL IRON CHELATORS IN PAEDIATRIC PATIENTS WITH TRANSFUSION-DEPENDENT HAEMOGLOBINOPATHIES
por: Della Pasqua, O.D.P., et al.
Publicado: (2023)

The Pharmacokinetics of The Biliary Excretion of Ciprofloxacin
por: Ball, C. S., et al.
Publicado: (1989)

Pharmacokinetics of ranitidine during hemodiafiltration
por: Fuhrmann, V, et al.
Publicado: (2008)

Plasma cholinesterase activity in patients during peritoneal dialysis
por: Popovic, L, et al.
Publicado: (2009)

Pharmacokinetic-pharmacodynamic analysis of ciprofloxacin in elderly Chinese patients with lower respiratory tract infections caused by Gram-negative bacteria
por: Gai, Xiao-Yan, et al.
Publicado: (2019)

Sustained high-efficiency daily diafiltration using a cytokine-adsorbing membrane in the treatment of patients with severe sepsis
por: Nishida, O, et al.
Publicado: (2011)

Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis
por: Zhang, Cindy X., et al.
Publicado: (2022)

1321. Population Pharmacokinetic (PK) and Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analyses for Dalbavancin in Pediatric Patients
por: Carrothers, Timothy J, et al.
Publicado: (2020)

A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis
por: Naik, Himanshu, et al.
Publicado: (2013)

Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions
por: Kussmann, Manuel, et al.
Publicado: (2019)

Random number generation for DNA-based security circuitry
por: Bogard, Christy M, et al.
Publicado: (2008)

Sustained low-efficiency dialysis (SLED) for acute lithium intoxication
por: Fiaccadori, Enrico, et al.
Publicado: (2008)

Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
por: Jacobsen, Lisbeth V., et al.
Publicado: (2015)

Ciprofloxacin Pharmacokinetics in Clinical Canine Patients
por: Papich, M.G.
Publicado: (2017)

Pharmacokinetic-Pharmacodynamic Model of Newly Developed Dexibuprofen Sustained Release Formulations
por: Muralidharan, Selvadurai
Publicado: (2012)

Intravenous paracetamol pharmacokinetics in neonates: a pooled analysis
por: Allegaert, K, et al.
Publicado: (2011)

607. Establishing Pharmacokinetic Profile of β -lactams in Critically Ill Patients on Continuous Sustained Low-efficiency Dialysis (C-SLED) 
por: Shah, Madiha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u0sleeaff7ldde8o1ij8dsnesq